Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 11Breast 11Thoracic 4Gynecologic 3Other hematologic neoplasm 2Sarcoma 1Other 1Myeloid 1Lymphoid 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Obesity 373Neoplasms 134Breast Neoplasms 95Mucositis 94Overweight 91Sexual Dysfunction, Physiological 90Polycystic Ovary Syndrome 89Dyspnea 56Motor Activity 54Weight Loss 38Constipation 35Diabetes Mellitus 33Prostatic Neoplasms 32Head and Neck Neoplasms 30Colorectal Neoplasms 30Endometrial Neoplasms 26Lung Neoplasms 25Depression 25Diabetes Mellitus, Type 2 23Cardiovascular Diseases 23Multiple Endocrine Neoplasia Type 1 22Pain 20Anxiety Disorders 20Insulin Resistance 19Obesity, Morbid 18Pulmonary Disease, Chronic Obstructive 17Hypertension 17Sexual Dysfunctions, Psychological 16Metabolic Syndrome 16Colonic Neoplasms 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Patient Compliance × Other × Clear all
NCT07058207 2025-07-28

CANOBESE

Institut d'Investigació Biomèdica de Bellvitge

Phase NA Recruiting
50 enrolled
Other

Motor Activity, Neoplasms, Obesity, Patient Compliance, Patient Dropouts, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡